BioLineRx Ltd. (BLRX) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
BLRX currently has 2.61B outstanding shares. with moderate dilution risk from 817M authorized shares representing 31.3% potential dilution. The company has diluted shareholders by 16.94% over the past 2 years through share issuances.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Mar 23, 2026 |
20-F filing | 2610.8M shares outstanding |
2.6B | 820M |
| Mar 31, 2025 |
20-F filing | 2232.6M shares outstanding |
2.2B | 1.2B |
| Mar 26, 2024 |
20-F filing | 1086.6M shares outstanding |
1.1B | 2.3B |
| Dec 29, 2023 |
F-3 filing: BioLineRx Ltd. may offer, issue, and sell from time to time up to $250,000,000 of our ordinary shares, including in the form of American Depositary Shares, or ADSs, warrants to purchase ordinary shares, including in the form of ADSs, debt securities, subscription rights and a combination of such securities, separately or as units, in one or more offerings. |
970M | 2.5B |
| Mar 22, 2023 |
20-F filing | 923.0M shares outstanding |
920M | 150M |
| Mar 16, 2022 |
20-F filing | 715.2M shares outstanding |
720M | 350M |
| Feb 23, 2021 |
20-F filing | 349.2M shares outstanding |
350M | 720M |
| Feb 23, 2021 |
POS AM filing: This POS AM filing relates to the offering of up to 41,949,555 ordinary shares represented by 2,796,637 ADSs issuable upon the exercise of warrants originally issued in the May 2020 and June 2020 Private Placements. |
350M | 720M |
| Dec 31, 2020 |
F-3 filing: BioLineRx Ltd. is filing an F-3 to offer up to $150,000,000 of ordinary shares, American Depositary Shares, warrants, debt securities, subscription rights and units. |
300M | 770M |
| Aug 07, 2020 |
POS AM filing: This is a POS AM filing for BioLineRx Ltd. registering for resale 120,537,030 ordinary shares represented by 8,035,802 ADSs issuable upon the exercise of warrants held by the selling shareholders. |
300M | 0 |
| Jun 26, 2020 |
F-1 filing: This F-1 filing registers for resale 120,537,030 ordinary shares represented by 8,035,802 ADSs issuable upon the exercise of warrants held by the selling shareholders. |
300M | 0 |
| Mar 12, 2020 |
20-F filing | 171.3M shares outstanding |
170M | 0 |